Broomfield A, Zuberi K, Mercer J, Moss G, Finnegan N, Hensman P, Walker R, Bukhari S, Wright N B, Stewart F, Jones S A, Ramirez R
Willink Biochemical Genetics Unit, Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, M13 9WL, UK.
Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Rd, Manchester, M13 9PL, UK.
Childs Nerv Syst. 2018 Sep;34(9):1705-1716. doi: 10.1007/s00381-018-3823-9. Epub 2018 Jun 26.
This study examines the long-term outcomes of paediatric Morquio (MPS IVA) patients undergoing cervical spine surgery and evaluates the factors that impacting this.
A retrospective review was performed on all MPS IVA patients undergoing cervical spine surgery, since the introduction of standardised neuroradiological screening. The impact of preoperative neurological status, growth, genotype and radiological status on outcome is assessed, whilst long-term surgical, radiological and neurological outcomes are documented.
Twenty-six of the eighty-two MPS IVA patients (31%) reviewed underwent cervical spine surgery at a median age of 6.1 years (range, 1.45 to 15.24). Preoperatively, cord signal change was seen in 11 patients with 5 being myelopathic; however, 6 clinically manifesting patients had no overt cord signal change. Postoperatively, none of the 14 preoperatively clinically asymptomatic patients followed long term progressed neurologically during a median follow-up of 77.5 months (range = 18-161). Of the ten preoperatively clinically symptomatic patients who were followed up for the same duration, seven continued to deteriorate, two initially improved and one remained stable. Radiological follow-up performed for a median duration of 7 years (range = 0.5-16) has shown a degree of stenosis at the level immediately caudal to the termination of the graft in 76% of patients, though only one has become clinically symptomatic and required revision.
Once clinically elicitable neurological signs become evident in patients with MPS IVA, they tend to progress despite surgical intervention. Referring clinicians should also not be falsely reassured by the lack of T2 spinal cord signal change but should consider surgical intervention in the face of new clinical symptomology or radiological signs of progressive canal stenosis or instability.
本研究探讨接受颈椎手术的儿科莫尔基奥氏病(黏多糖贮积症IVA型,MPS IVA)患者的长期预后,并评估影响其预后的因素。
自引入标准化神经放射学筛查以来,对所有接受颈椎手术的MPS IVA患者进行回顾性研究。评估术前神经状态、生长情况、基因型和放射学状态对预后的影响,同时记录长期手术、放射学和神经学预后情况。
在接受回顾的82例MPS IVA患者中,26例(31%)接受了颈椎手术,中位年龄为6.1岁(范围1.45至15.24岁)。术前,11例患者出现脊髓信号改变,其中5例有脊髓病;然而,6例有临床表现的患者没有明显的脊髓信号改变。术后,14例术前临床无症状的患者在中位随访77.5个月(范围18至161个月)期间,长期神经功能均未进展。在随访相同时间的10例术前有临床症状的患者中,7例病情继续恶化,2例最初有所改善,1例保持稳定。中位随访7年(范围0.5至16年)的放射学随访显示,76%的患者在移植终止水平的紧邻尾侧出现一定程度的狭窄,尽管只有1例出现临床症状并需要翻修手术。
MPS IVA患者一旦出现临床可引出的神经体征,即使进行手术干预,病情仍倾向于进展。转诊医生也不应因T2脊髓信号未改变而被误导,面对新的临床症状或进行性椎管狭窄或不稳定的放射学征象时,应考虑手术干预。